Allelic Loss Is Often the First Hit in the Biallelic Inactivation of the p53 and DPC4 Genes During Pancreatic Carcinogenesis
- 1 May 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (5), 1677-1683
- https://doi.org/10.1016/s0002-9440(10)64123-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pancreatic Intraepithelial NeoplasiaThe American Journal of Surgical Pathology, 2001
- Molecular Analysis of Microdissected Tumors and Preneoplastic Intraductal Lesions in Pancreatic CarcinomaThe American Journal of Pathology, 2000
- Genetic Progression and Divergence in Pancreatic CarcinomaThe American Journal of Pathology, 2000
- Genetic Progression in the Pancreatic DuctsThe American Journal of Pathology, 2000
- Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic AdenocarcinomasThe American Journal of Pathology, 2000
- Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNAProceedings of the National Academy of Sciences, 1996
- DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1Science, 1996
- Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic diseaseGastroenterology, 1996
- Overexpression of p53 Protein in Adenocarcinoma of the PancreasAmerican Journal of Clinical Pathology, 1994
- Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesisVirchows Archiv, 1980